UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Journal of clinical oncology, 2008-01, Vol.26 (1), p.76-82

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide

Cancers, 2024-02, Vol.16 (5), p.936

2024

Link zum Volltext

Verfügbarkeit prüfen

A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice

Molecules (Basel, Switzerland), 2018-11, Vol.23 (11), p.2918

2018

Link zum Volltext

Verfügbarkeit prüfen

NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity

Cancers, 2022-12, Vol.14 (24), p.6065

2022

Link zum Volltext

Verfügbarkeit prüfen

NPPB is a novel candidate biomarker expressed by cancer‐associated fibroblasts in epithelial ovarian cancer

International journal of cancer, 2015-03, Vol.136 (6), p.1390-1401

2015

Link zum Volltext

Verfügbarkeit prüfen

Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia

Cancers, 2021-07, Vol.13 (14), p.3385

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemical surface modification of parylene C for enhanced protein immobilization and cell proliferation

Acta biomaterialia, 2011-10, Vol.7 (10), p.3746-3756

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract C032: A novel integrin-targeted therapeutic agent for ovarian cancer

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C032-C032

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of ^sup 64^Cu-labeled disintegrin for imaging tumor metastasis in an experimental model of human prostate cancer

The Journal of nuclear medicine (1978), 2017-05, Vol.58, p.921

2017

Link zum Volltext

Verfügbarkeit prüfen

Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy

Journal of neurosurgery, 2005-12, Vol.103 (6), p.1058

2005

Link zum Volltext

Verfügbarkeit prüfen

Preliminary efficacy evaluation of ^sup 64^Cu-labeled disintegrin in tracking response to docetaxel treatment in prostate tumor-bearing mice

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1267

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models

Journal of neurosurgery, 2020-03, Vol.132 (3), p.959-967

2020

Link zum Volltext

Verfügbarkeit prüfen

The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model

Journal of neurosurgery, 2005-09, Vol.103 (3), p.526

2005

Link zum Volltext

Verfügbarkeit prüfen

Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer

Amino acids, 2019-11, Vol.51 (10-12), p.1569-1575

2019

Link zum Volltext

Verfügbarkeit prüfen

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

Oncotarget, 2018-12, Vol.9 (97), p.37026-37041

2018

Link zum Volltext

Verfügbarkeit prüfen

Preclinical evaluation of a 64 Cu-labeled disintegrin for PET imaging of prostate cancer

Amino acids, 2019-11, Vol.51 (10-12), p.1569

2019

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro

Therapeutic advances in medical oncology, 2019, Vol.11, p.1758835919891567-1758835919891567

2019

Link zum Volltext

Verfügbarkeit prüfen

Fibrolase: trials and tribulations

Toxins, 2010-04, Vol.2 (4), p.793-808

2010

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma

Therapeutic advances in medical oncology, 2019-12, Vol.11

2019

Link zum Volltext

Verfügbarkeit prüfen

Using Social Marketing to Engage Extension Audiences: Lessons from an Effort Targeting Woodland Owners

Journal of extension, 2017-06, Vol.55 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice

Neuro-oncology advances, 2020-01, Vol.2 (1), p.vdaa160-vdaa160

2020

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration

Journal of medical toxicology, 2013-06, Vol.9 (2), p.139-143

2013

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration

Journal of medical toxicology, 2014-09, Vol.10 (3), p.331-331

2014

Link zum Volltext

Verfügbarkeit prüfen

The Design of Elastin-Like Polypeptides (ELPs) as a Nanoparticulate-Based Therapeutic and Diagnostic Imaging Agent

Advanced materials research, 2014-08, Vol.1024, p.287-291

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploring the Challenges of Environmental Planning and Green Design: Cases from Europe and the USA

Planning theory & practice, 2012-03, Vol.13 (1), p.113-174

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide

A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice

NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity

NPPB is a novel candidate biomarker expressed by cancer‐associated fibroblasts in epithelial ovarian cancer

Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia

Chemical surface modification of parylene C for enhanced protein immobilization and cell proliferation

Abstract C032: A novel integrin-targeted therapeutic agent for ovarian cancer

Evaluation of ^sup 64^Cu-labeled disintegrin for imaging tumor metastasis in an experimental model of human prostate cancer

Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy

Preliminary efficacy evaluation of ^sup 64^Cu-labeled disintegrin in tracking response to docetaxel treatment in prostate tumor-bearing mice

Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models

The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model

Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

Preclinical evaluation of a 64 Cu-labeled disintegrin for PET imaging of prostate cancer

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro

Fibrolase: trials and tribulations

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma

Using Social Marketing to Engage Extension Audiences: Lessons from an Effort Targeting Woodland Owners

Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice

Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration

Erratum to: Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration

The Design of Elastin-Like Polypeptides (ELPs) as a Nanoparticulate-Based Therapeutic and Diagnostic Imaging Agent

Exploring the Challenges of Environmental Planning and Green Design: Cases from Europe and the USA

Suchergebnisse filtern